Antioxidant and Anti-Inflammatory Properties of Cherry Extract: Nanosystems-Based Strategies to Improve Endothelial

Denise Beconcini1,2,3, Francesca Felice2, Angela Fabiano3

  • 1Department of Life Sciences, University of Siena, via Aldo Moro 2, 53100 Siena, Italy.

Foods (Basel, Switzerland)
|February 22, 2020
PubMed

Insights

Cherry extract (CE) demonstrates significant antioxidant and anti-inflammatory effects, potentially combating cardiovascular diseases. Novel nanoparticle delivery systems enhance CE bioavailability and absorption for improved therapeutic outcomes.

Area of Science:

  • Nutraceuticals and Cardiovascular Health
  • Cellular Biology and Inflammation
  • Nanotechnology in Drug Delivery

Background:

  • Flavonoids in cherry fruit offer protection against oxidative stress, inflammation, and endothelial dysfunction, key factors in atherosclerosis and cardiovascular diseases (CVD).
  • Limited fresh cherry availability necessitates research into cherry extract (CE) as a potent nutraceutical alternative.
  • Limited studies exist on the antioxidant and anti-inflammatory activities of CE, particularly its mechanism of action.

Purpose of the Study:

  • To review the antioxidant and anti-inflammatory activities of cherry extract (CE).
  • To investigate the mechanism of action of CE in an in vitro model of endothelial dysfunction.
  • To present and discuss strategies for improving CE bioavailability and absorption using nanotechnology.

Main Methods:

  • An in vitro model using Human Umbilical Vein Endothelial Cells (HUVEC) was employed to assess CE's antioxidant and anti-inflammatory effects.
  • Cells were subjected to stress to induce inflammation and endothelial dysfunction, mimicking disease conditions.
  • Chitosan derivative nanoparticles (Ch-der NP) and poly(lactic-co-glycolic) acid nanoparticles (PLGA NP) were utilized to evaluate enhanced CE delivery.

Main Results:

  • Cherry extract (CE) demonstrated significant antioxidant and anti-inflammatory activities in the HUVEC model.
  • Chitosan derivative nanoparticles (Ch-der NP) showed improved mucoadhesive properties and cellular interaction, leading to enhanced polyphenol absorption compared to PLGA NP.
  • Nanoparticle systems offer a promising strategy to overcome the gastrointestinal degradation of CE polyphenols and improve bioavailability.

Conclusions:

  • Cherry extract possesses significant nutraceutical potential for managing cardiovascular disease risk factors.
  • Nanotechnology, particularly chitosan-based nanoparticles, can effectively enhance the bioavailability and cellular uptake of CE polyphenols.
  • Further research into nanosystems for CE and other nutraceuticals is warranted for improved therapeutic applications and safety.